Literature DB >> 16988246

Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid.

Christian Theilacker1, Zbigniew Kaczynski, Andrea Kropec, Francesca Fabretti, Tatjana Sange, Otto Holst, Johannes Huebner.   

Abstract

A teichoic acid (TA)-like polysaccharide in Enterococcus faecalis has previously been shown to induce opsonic antibodies that protect against bacteremia after active and passive immunization. Here we present new data providing a corrected structure of the antigen and the epitope against which the opsonic antibodies are directed. Capsular polysaccharide isolated from E. faecalis strain 12030 by enzymatic digestion of peptidoglycan and chromatography (enzyme-TA) was compared with lipoteichoic acid (LTA) extracted using butanol and purified by hydrophobic-interaction chromatography (BuOH-LTA). Structural determinations were carried out by chemical analysis and nuclear magnetic resonance spectroscopy. Antibody specificity was assessed by enzyme-linked immunosorbent assay and the opsonophagocytosis assay. After alanine ester hydrolysis, there was structural identity between enzyme-TA and BuOH-LTA of the TA-parts of the two molecules. The basic enterococcal LTA structure was confirmed: 1,3-poly(glycerol phosphate) nonstoichiometrically substituted at position C-2 of the glycerol residues with d-Ala and kojibiose. We also detected a novel substituent at position C-2, [D-Ala-->6]-alpha-D-Glcp-(1-->2-[D-Ala-->6]-alpha-D-Glcp-1-->). Antiserum raised against enzyme-TA bound equally well to BuOH-LTA and dealanylated BuOH-LTA as to the originally described enzyme-TA antigen. BuOH-LTA was a potent inhibitor of opsonophagocytic killing by the antiserum to enzyme-TA. Immunization with antibiotic-killed whole bacterial cells did not induce a significant proportion of antibodies directed against alanylated epitopes on the TA, and opsonic activity was inhibited completely by both alanylated and dealanylated BuOH-LTA. In summary, the E. faecalis strain 12030 enzyme-TA is structurally and immunologically identical to dealanylated LTA. Opsonic antibodies to E. faecalis 12030 are directed predominantly to nonalanylated epitopes on the LTA molecule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988246      PMCID: PMC1594888          DOI: 10.1128/IAI.00570-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Structure of intracellular teichoic acids from group D streptococci.

Authors:  A J WICKEN; J BADDILEY
Journal:  Biochem J       Date:  1963-04       Impact factor: 3.857

3.  The quantitative histochemistry of brain. I. Chemical methods.

Authors:  O H LOWRY; N R ROBERTS; K Y LEINER; M L WU; A L FARR
Journal:  J Biol Chem       Date:  1954-03       Impact factor: 5.157

4.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Authors: 
Journal:  Am J Infect Control       Date:  2004-12       Impact factor: 2.918

5.  Enterococcus faecalis antigens in human infections.

Authors:  Y Xu; L Jiang; B E Murray; G M Weinstock
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

6.  Structural and serological characterisation of the O-antigenic polysaccharide of the lipopolysaccharide from Acinetobacter haemolyticus strain ATCC 17906.

Authors:  S R Haseley; O Holst; H Brade
Journal:  Eur J Biochem       Date:  1997-03-15

7.  Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.

Authors:  Y Wang; J Huebner; A O Tzianabos; G Martirosian; D L Kasper; G B Pier
Journal:  Carbohydr Res       Date:  1999-03-31       Impact factor: 2.104

8.  Role of lipoteichoic acid in the phagocyte response to group B streptococcus.

Authors:  Philipp Henneke; Siegfried Morath; Satoshi Uematsu; Stefan Weichert; Markus Pfitzenmaier; Osamu Takeuchi; Andrea Müller; Claire Poyart; Shizuo Akira; Reinhard Berner; Giuseppe Teti; Armin Geyer; Thomas Hartung; Patrick Trieu-Cuot; Dennis L Kasper; Douglas T Golenbock
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

9.  Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.

Authors:  J Huebner; Y Wang; W A Krueger; L C Madoff; G Martirosian; S Boisot; D A Goldmann; D L Kasper; A O Tzianabos; G B Pier
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

Review 10.  Rationale for the development of immunotherapy regimens against enterococcal infections.

Authors:  Christian Theilacker; Wolfgang A Krueger; Andrea Kropec; Johannes Huebner
Journal:  Vaccine       Date:  2004-12-06       Impact factor: 3.641

View more
  32 in total

1.  Detection and characterization of bacterial polysaccharides in drug-resistant enterococci.

Authors:  Liaqat Ali; Hubert E Blum; Türkân Sakιnç
Journal:  Glycoconj J       Date:  2019-06-22       Impact factor: 2.916

2.  Detection of opsonic antibodies against Enterococcus faecalis cell wall carbohydrates in immune globulin preparations.

Authors:  M Hufnagel; K Sixel; F Hammer; A Kropec; I G Sava; C Theilacker; R Berner; J Huebner
Journal:  Infection       Date:  2014-05-23       Impact factor: 3.553

Review 3.  Envelope Structures of Gram-Positive Bacteria.

Authors:  Mithila Rajagopal; Suzanne Walker
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 4.  The rise of the Enterococcus: beyond vancomycin resistance.

Authors:  Cesar A Arias; Barbara E Murray
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

5.  Intrinsic resistance of Enterococcus faecalis strains to ΦEf11 phage endolysin is associated with the presence of ΦEf11 prophage.

Authors:  Hongming Zhang; Roy H Stevens
Journal:  Arch Virol       Date:  2020-11-09       Impact factor: 2.574

6.  Impact of antibiotic treatment and host innate immune pressure on enterococcal adaptation in the human bloodstream.

Authors:  Daria Van Tyne; Abigail L Manson; Mark M Huycke; John Karanicolas; Ashlee M Earl; Michael S Gilmore
Journal:  Sci Transl Med       Date:  2019-04-10       Impact factor: 17.956

7.  Secondary cell wall polymers of Enterococcus faecalis are critical for resistance to complement activation via mannose-binding lectin.

Authors:  Stefan Geiss-Liebisch; Suzan H M Rooijakkers; Agnieszka Beczala; Patricia Sanchez-Carballo; Karolina Kruszynska; Christian Repp; Tuerkan Sakinc; Evgeny Vinogradov; Otto Holst; Johannes Huebner; Christian Theilacker
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

8.  Lipoteichoic acid is important in innate immune responses to gram-positive bacteria.

Authors:  Ho Seong Seo; Suzanne M Michalek; Moon H Nahm
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

9.  Comparative genomic analysis of pathogenic and probiotic Enterococcus faecalis isolates, and their transcriptional responses to growth in human urine.

Authors:  Heidi C Vebø; Margrete Solheim; Lars Snipen; Ingolf F Nes; Dag A Brede
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

10.  Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells.

Authors:  Irina G Sava; Fuming Zhang; Ioana Toma; Christian Theilacker; Boyangzhi Li; Thomas F Baumert; Otto Holst; Robert J Linhardt; Johannes Huebner
Journal:  J Biol Chem       Date:  2009-04-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.